Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Zomedica Pharmaceuticals (ZOM – Research Report) today and set a price target ...

We currently have no ZOM Stock Split History on this stock.

Find the latest Zomedica Corp. ZOM analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.